Patent US4153700A successfully refreshed from Google Patents.
US4153700A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of the acute after-effects resulting from alcohol ingestion
Assignee: Lake Shore Roentgenology Ltd
•
Filing: 1977-06-10
•
Granted: 1979-05-08
•
Expires: 1997-06-10
Abstract
Abstract A composition and method for the prevention of alcohol-induced thirst and/or fatigue and/or nausea, as well as other less common after-effects resulting from excess alcohol ingestion wherein the composition is formulated to contain a dibenzocycloheptatriene derivative such as cyproheptadine and a lysergic acid derivative such as ergotamine. It has been found that these two classes of antagonists of 5-hydroxytryptamine act synergistically in minimizing or preventing an acute inflammatory reaction otherwise resulting from ingestion of excess alcohol.
Inventors
- 👤 Carl S. Rosenberg
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 16:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/48
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
47 words
A composition for use in the treatment of the acute after effects resulting from alcohol ingestion consisting essentially of ergotamine tartrate and cyproheptadine, the ergotamine tartrate being present in a weight ratio within the range 1 to 12 parts by weight per part by weight of cyproheptadine.
Claim 2
Dependent Claim
47 words
A composition for use in the treatment of the acute after effects resulting from alcohol ingestion consisting essentially of ergotamine tartrate and cyproheptadine, the ergotamine tartrate being present in a weight ratio within the range 1 to 12 parts by weight per part by weight of cyproheptadine.
Claim 3
Independent Claim
57 words
A method for prevention of alcohol induced thirst, fatigue and/or nausea comprising administering to a person who has ingested alcohol an effective amount of a composition consisting essentially of ergotamine tartrate and cyproheptadine, the ergotamine tartrate being present in a weight ratio within the range 1 to 12 parts by weight per part by weight of cyproheptadine.
Claim 4
Independent Claim
57 words
A method for prevention of alcohol induced thirst, fatigue and/or nausea comprising administering to a person who has ingested alcohol an effective amount of a composition consisting essentially of ergotamine tartrate and cyproheptadine, the ergotamine tartrate being present in a weight ratio within the range 1 to 12 parts by weight per part by weight of cyproheptadine.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-05-07 | 1982-11-06 | 1983-05-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-05-07 | 1986-11-06 | 1987-05-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-05-07 | 1990-11-06 | 1991-05-08 | $7700.00 | Window Closed / Lapsed |